GLP-1 Medications for Weight Loss
Complete Guide 2025
Quick Summary
GLP-1 medications (semaglutide, tirzepatide) cause 15-20% body weight loss by mimicking natural fullness hormones, reducing appetite and slowing digestion. FDA-approved for BMI 30+ or BMI 27+ with conditions. Semaglutide (Wegovy/Ozempic) costs $99-350/month; tirzepatide (Mounjaro/Zepbound) costs $350-550/month for brand-name, $99-299/month for compounded versions through online clinics. Weekly injections required indefinitely—weight regains within 6-12 months if stopped.
- Average weight loss: semaglutide 15-17% of body weight, tirzepatide 20-22%; results appear in 4-8 weeks with peak at 12-18 months
- Common side effects: nausea (40-50%), vomiting (10-20%), diarrhea (20-30%)—usually mild and subside after 4-8 weeks
- Qualification: BMI 30+ or BMI 27+ with obesity-related conditions (diabetes, high blood pressure, sleep apnea); requires prescription
- Must continue indefinitely for results—studies show 70% of weight regained within 12 months of stopping medication
What Are GLP-1 Medications?
GLP-1 (glucagon-like peptide-1) medications are a class of injectable drugs originally developed for type 2 diabetes that have proven remarkably effective for weight loss. These medications mimic a natural hormone your body produces after eating, leading to reduced appetite, increased feelings of fullness, and significant weight loss.
Popular GLP-1 medications:
- Semaglutide: Ozempic (diabetes), Wegovy (weight loss)
- Tirzepatide: Mounjaro (diabetes), Zepbound (weight loss)
- Liraglutide: Victoza (diabetes), Saxenda (weight loss)
Key facts:
- Average weight loss: 15-20% of body weight
- FDA-approved for weight management
- Weekly injections (most)
- Require ongoing use to maintain results
- Prescription only
How GLP-1 Medications Work
The Science Behind GLP-1
GLP-1 is a natural hormone your intestines produce after eating. It:
- Signals your brain that you’re full
- Slows stomach emptying (keeps you satisfied longer)
- Reduces appetite and cravings
- Helps regulate blood sugar
GLP-1 medications are synthetic versions that last much longer than natural GLP-1 (days vs. minutes), providing sustained appetite suppression and weight loss effects.
Effects on Your Body
Appetite and Satiety:
- Dramatically reduces hunger
- Creates strong feeling of fullness with less food
- Reduces food cravings (especially for high-calorie foods)
- Some describe it as “food noise” going quiet
Stomach and Digestion:
- Slows gastric emptying (food stays in stomach longer)
- Increases satisfaction from smaller portions
- May cause nausea initially (usually improves)
Blood Sugar:
- Improves insulin sensitivity
- Lowers blood sugar (beneficial for pre-diabetes/diabetes)
- Reduces HbA1c
Weight Loss:
- Average 15-20% total body weight loss
- More effective than lifestyle changes alone
- Most weight loss occurs in first 6-12 months
Popular GLP-1 Medications Compared
Semaglutide (Ozempic/Wegovy)
Ozempic:
- FDA-approved for type 2 diabetes
- Widely prescribed off-label for weight loss
- Doses: 0.25mg, 0.5mg, 1mg, 2mg weekly
Wegovy:
- FDA-approved specifically for weight loss
- Same medication as Ozempic, higher doses
- Doses: 0.25mg up to 2.4mg weekly
Clinical Results:
- Average weight loss: 15% of body weight (33 lbs if starting at 220 lbs)
- 68-week study: Lost 15.3 kg (33.7 lbs) vs. 2.6 kg (5.7 lbs) placebo
- ~70% of people lose 10%+ of body weight
Administration:
- Once-weekly subcutaneous injection
- Inject in abdomen, thigh, or upper arm
Cost:
- Ozempic: $900-1,000/month without insurance
- Wegovy: $1,300-1,500/month without insurance
- Compounded semaglutide: $200-400/month through telehealth
Tirzepatide (Mounjaro/Zepbound)
Mounjaro:
- FDA-approved for type 2 diabetes
- Often prescribed off-label for weight loss
- Doses: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg weekly
Zepbound:
- FDA-approved for weight loss (newer)
- Same medication as Mounjaro
- Doses: 2.5mg up to 15mg weekly
Clinical Results:
- Average weight loss: 20% of body weight (44 lbs if starting at 220 lbs)
- 72-week study: Lost 20.9 kg (46 lbs) at highest dose
- More effective than semaglutide in head-to-head trials
How it’s different:
- Dual agonist: Activates both GLP-1 and GIP receptors
- Generally more weight loss than semaglutide
- Potentially fewer GI side effects
Cost:
- Mounjaro: $1,000-1,100/month without insurance
- Zepbound: $1,000-1,200/month without insurance
- Compounded tirzepatide: $400-600/month through telehealth
Liraglutide (Saxenda)
Older GLP-1 medication:
- Daily injection (not weekly)
- Effective but less convenient
- Average weight loss: 8-9% body weight
- Less popular since semaglutide/tirzepatide available
Comparison Table
| Medication | Avg Weight Loss | Injection Frequency | Cost/Month | Notes |
|---|---|---|---|---|
| Semaglutide (Wegovy) | 15% body weight | Weekly | $1,300 | Most studied, effective |
| Tirzepatide (Zepbound) | 20% body weight | Weekly | $1,200 | Most effective, dual agonist |
| Liraglutide (Saxenda) | 8-9% body weight | Daily | $1,400 | Older, less convenient |
| Compounded versions | Similar | Weekly | $200-600 | Affordable option |
Who Should Use GLP-1 Medications?
FDA-Approved Criteria
GLP-1s approved for weight loss if you have:
- BMI ≥30 (obese), OR
- BMI ≥27 (overweight) with weight-related health condition:
- Type 2 diabetes or pre-diabetes
- High blood pressure
- High cholesterol
- Cardiovascular disease
- Sleep apnea
Best candidates:
- Have tried diet and exercise without success
- Willing to commit to long-term treatment
- Can afford cost (or have insurance coverage)
- Don’t have contraindications
Who Should NOT Use GLP-1s
Contraindications:
- Personal or family history of medullary thyroid cancer
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)
- Pregnant or trying to become pregnant
- Breastfeeding
- History of pancreatitis
- Severe gastrointestinal disease
- History of diabetic retinopathy (with caution)
Use caution if:
- History of eating disorders
- Severe depression or suicidal ideation
- Taking other weight loss medications
Starting GLP-1 Medication: What to Expect
Dose Titration Schedule
Semaglutide (Wegovy) typical schedule:
- Month 1: 0.25mg weekly
- Month 2: 0.5mg weekly
- Month 3: 1.0mg weekly
- Month 4: 1.7mg weekly
- Month 5+: 2.4mg weekly (maintenance)
Tirzepatide (Zepbound) typical schedule:
- Month 1: 2.5mg weekly
- Month 2: 5.0mg weekly
- Month 3: 7.5mg weekly
- Month 4: 10mg weekly
- Month 5+: 10-15mg weekly (maintenance)
Why slow titration?
- Reduces side effects (especially nausea)
- Allows body to adjust
- Improves tolerability
Timeline for Results
Week 1-4:
- Reduced appetite noticed immediately
- Less hunger between meals
- May lose 2-5 lbs
- Some nausea possible
Month 2-3:
- Weight loss accelerates
- 1-2 lbs per week typical
- Appetite suppression strong
- Side effects usually improving
Month 4-6:
- Steady weight loss continues
- May lose 10-15% of starting weight
- People start noticing your weight loss
- Energy may improve
Month 6-12:
- Maximum weight loss typically reached
- ~15-20% total body weight lost
- Weight stabilizes
- Continue medication to maintain
Administration Tips
Injection technique:
- Subcutaneous (under skin, not into muscle)
- Rotate injection sites (abdomen, thigh, upper arm)
- Use new needle each time
- Inject same day each week
Reducing side effects:
- Take with food in stomach (can reduce nausea)
- Stay well-hydrated
- Eat smaller, more frequent meals
- Avoid high-fat, greasy foods
- Increase fiber intake to prevent constipation
Side Effects and How to Manage Them
Common Side Effects (Most People Experience These)
Gastrointestinal (Most Common):
- Nausea (most common, usually temporary)
- Diarrhea or constipation
- Vomiting
- Stomach pain
- Bloating and gas
- Heartburn/acid reflux
Management strategies:
- Eat smaller meals
- Avoid fatty, greasy, or spicy foods
- Stay hydrated
- Take anti-nausea medication if prescribed
- Symptoms usually improve after 4-8 weeks
Other Common:
- Fatigue
- Headache
- Dizziness
- Injection site reactions
Serious Side Effects (Rare but Important)
Seek medical attention if you experience:
Pancreatitis:
- Severe abdominal pain that won’t go away
- Pain radiating to back
- Nausea and vomiting
- Stop medication immediately and see doctor
Gallbladder problems:
- Pain in upper right abdomen
- Jaundice (yellowing of skin/eyes)
- Fever
- Clay-colored stools
Severe allergic reaction:
- Difficulty breathing
- Swelling of face, lips, tongue
- Severe rash
Kidney problems:
- Dehydration from vomiting/diarrhea can stress kidneys
- Stay well-hydrated
Hypoglycemia (if also on diabetes medications):
- Shakiness, sweating, confusion
- May need to adjust other diabetes medications
Vision changes:
- Diabetic retinopathy worsening (rare)
- Report any vision changes
Long-Term Considerations
“Ozempic face”:
- Rapid weight loss can cause facial volume loss
- Skin may appear saggy
- More noticeable in older individuals
- Not harmful, purely cosmetic
Muscle loss:
- GLP-1s cause fat AND muscle loss
- Resistance training recommended
- Adequate protein intake essential (1g per lb body weight)
Gallstones:
- Rapid weight loss increases gallstone risk
- ~3% develop gallstones
Cost and Insurance Coverage
Brand-Name Medication Costs
Without insurance:
- Wegovy (semaglutide): $1,300-1,500/month
- Zepbound (tirzepatide): $1,000-1,200/month
- Mounjaro: $1,000-1,100/month
- Ozempic: $900-1,000/month
Annual cost: $12,000-18,000
Insurance Coverage
Diabetes indication (Ozempic, Mounjaro):
- Often covered by insurance
- Copays: $25-100/month typically
Weight loss indication (Wegovy, Zepbound):
- Many insurance plans don’t cover weight loss medications
- Medicare doesn’t cover weight loss drugs
- Some commercial plans cover with prior authorization
Prior authorization requirements:
- BMI ≥30 or ≥27 with comorbidities
- Documented weight loss attempts
- Medical necessity letter from doctor
Affordable Alternatives: Compounded GLP-1s Through Telehealth
Best for Affordability: Hims offers compounded semaglutide starting at $199/month with medical consultations, weight loss coaching, and discreet delivery. Great for cost-conscious users who want comprehensive support.
Best Overall Program: Ro provides compounded semaglutide ($145-290/month) and tirzepatide with personalized dosing, ongoing physician support, and nutrition guidance. Ideal if you want structured medical supervision.
Best for Budget: Henry Meds specializes in affordable GLP-1 medications with compounded semaglutide at $297/month including consultations and shipping. Perfect if you want the lowest price with quality care.
Compounded semaglutide details:
- $145-400/month depending on provider and dose
- Same active ingredient as Wegovy/Ozempic
- Made by licensed 503B compounding pharmacies
- Legal due to ongoing Wegovy shortages
- Quality varies by pharmacy
Compounded tirzepatide details:
- $350-600/month typical pricing
- Same active ingredient as Zepbound/Mounjaro
- More effective than semaglutide (20% vs 15% weight loss)
Compare all weight loss services to find the best option for your budget and needs.
Pros:
- Much more affordable than brand-name ($1,000-1,500 savings/month)
- Convenient telehealth delivery
- No insurance hassles or prior authorization
- Ongoing medical support included
Cons:
- Not FDA-approved (though legally compounded)
- Quality control less rigorous than brand-name
- Insurance won’t cover compounded versions
- Long-term supply uncertain if shortages end
Savings Programs
Manufacturer savings cards:
- Wegovy: $500 off with savings card (if eligible)
- Mounjaro: $25 copay savings program
- Check manufacturer websites for current offers
Do You Need to Stay on GLP-1s Forever?
The Reality of Long-Term Use
Most weight regain occurs after stopping:
- Studies show ~70% of weight comes back within a year of stopping
- Appetite returns to pre-treatment levels
- “Food noise” comes back
Why this happens:
- GLP-1s don’t cure obesity—they manage it
- Underlying biology unchanged
- Think of it like blood pressure medication
Current medical thinking:
- Obesity is a chronic disease requiring ongoing treatment
- Most people need long-term or lifelong use
- Similar to diabetes or hypertension medications
Can You Ever Stop?
Some people successfully stop if:
- They’ve established sustainable healthy habits
- Significant lifestyle changes made
- Close monitoring and early intervention if weight returns
Strategies for stopping:
- Very slow tapering (reduce dose gradually over months)
- Aggressive diet and exercise program
- Regular monitoring
- Restart early if weight trends upward
Realistic expectations:
- Most people need ongoing treatment
- Intermittent use may work for some
- Maintenance dose may be lower than weight loss dose
GLP-1s vs. Other Weight Loss Approaches
GLP-1s vs. Diet and Exercise Alone
Diet/Exercise:
- Average weight loss: 5-10% with intensive program
- Difficult to maintain long-term
- ~80% regain weight within 5 years
GLP-1s + Lifestyle:
- Average weight loss: 15-20%
- Better maintenance with continued use
- Makes diet/exercise much easier (reduced appetite)
Conclusion: GLP-1s are significantly more effective, but lifestyle still matters
GLP-1s vs. Other Weight Loss Medications
Phentermine:
- Stimulant, suppresses appetite
- 5-7% weight loss
- Can’t use long-term (tolerance, side effects)
Contrave (naltrexone/bupropion):
- 5-9% weight loss
- Oral medication
- Less effective than GLP-1s
Qsymia (phentermine/topiramate):
- 10-12% weight loss
- Can’t use long-term
GLP-1s are the most effective weight loss medications available.
GLP-1s vs. Bariatric Surgery
Bariatric surgery (gastric bypass, sleeve):
- Average weight loss: 25-30%
- One-time procedure
- Permanent anatomical change
- Risks of surgery
- Cost: $20,000-30,000
- Often covered by insurance
GLP-1s:
- 15-20% weight loss
- Ongoing medication
- Reversible
- No surgery
- Cost: $12,000-18,000/year
- Often not covered for weight loss
Surgery still more effective for severe obesity (BMI >40).
The Bottom Line
GLP-1 medications are highly effective for weight loss:
- 15-20% body weight loss typical
- Most effective weight loss medications available
- FDA-approved and safe when properly used
Best for:
- BMI ≥30 or BMI ≥27 with health conditions
- Those who’ve struggled with traditional weight loss
- People willing to commit to long-term use
- Those who can afford cost or have insurance coverage
Considerations:
- Expensive: $1,000-1,500/month brand-name, $200-600/month compounded
- Side effects common (mostly GI, usually temporary)
- Likely need ongoing use (not a cure)
- Require weekly injections
- Not covered by all insurance
Most important: GLP-1s are tools, not magic. They work best combined with healthy lifestyle changes. They make it dramatically easier to eat less and stick to a healthy diet, but they don’t do the work for you.
Talk to a healthcare provider to determine if GLP-1 medications are right for your weight loss goals.
Related Resources
Weight Loss Guides:
- Does Insurance Cover Weight Loss Telehealth?
- How Much Weight Can You Lose on Semaglutide?
- GLP-1 Side Effects Timeline
- Ozempic vs Wegovy Comparison
Service Reviews:
- Hims Review - Affordable semaglutide with coaching
- Ro Review - Comprehensive weight loss programs
- Henry Meds Review - Budget-friendly GLP-1s
Cost Comparisons:
This guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any weight loss medication.
Key Takeaways
- 1
GLP-1 medications (semaglutide, tirzepatide) produce 15-22% body weight loss by mimicking natural GLP-1 hormone, reducing appetite, slowing digestion, and increasing satiety after meals.
- 2
Semaglutide (Wegovy, Ozempic) causes 15-17% weight loss on average; tirzepatide (Mounjaro, Zepbound) is more effective with 20-22% average weight loss in clinical trials.
- 3
FDA-approved for adults with BMI 30+ (obesity) or BMI 27+ with weight-related conditions (diabetes, hypertension, sleep apnea)—not for cosmetic weight loss or BMI <27.
- 4
Common side effects include nausea (40-50%), vomiting (10-20%), and diarrhea (20-30%)—usually mild, occur during dose escalation, and subside within 4-8 weeks of treatment.
- 5
Cost: brand-name $900-1,400/month without insurance; compounded semaglutide $99-350/month; compounded tirzepatide $350-550/month through online weight loss clinics (Hims, Ro, Henry Meds).
- 6
GLP-1 medications require indefinite use—clinical trials show 70% of lost weight regained within 12 months of stopping; weight maintenance requires ongoing treatment or lifestyle changes.
Kai Nakano
Health Journalist & Men's Health Specialist
Medical review by Dr. Amara Okonkwo, PharmD, BCPS - Clinical Pharmacotherapy Specialist
View full profile →Common Questions About GLP-1 Medications for Weight Loss
Common questions about glp-1, semaglutide & tirzepatide answered by our research team.
Q How much weight can you lose on GLP-1 medications?
Average weight loss varies by medication: Semaglutide (Wegovy): 15-17% of body weight over 68 weeks (studies show 33-pound average for 200-pound person). Tirzepatide (Zepbound): 20-22% of body weight (44-pound average for 200-pound person). Liraglutide (Saxenda): 5-10% weight loss. Individual results vary—some lose 25-30%, others 8-12%. Maximum weight loss occurs at 12-18 months. Results depend on adherence, diet, exercise, and starting weight.
Q What's the difference between Ozempic, Wegovy, Mounjaro, and Zepbound?
Ozempic and Wegovy: both contain semaglutide; Ozempic FDA-approved for diabetes (0.5-2mg weekly), Wegovy for weight loss (2.4mg weekly). Mounjaro and Zepbound: both contain tirzepatide; Mounjaro for diabetes (5-15mg weekly), Zepbound for weight loss (5-15mg weekly). They're identical medications marketed differently. Tirzepatide (dual GIP/GLP-1) is more effective than semaglutide (GLP-1 only) but costs more. Many use diabetes versions off-label for weight loss at lower cost.
Q How much do GLP-1 medications cost?
Brand-name prices: Wegovy/Ozempic $900-1,400/month without insurance. Mounjaro/Zepbound $1,000-1,400/month. With insurance: $25-100/month copay if covered. Compounded semaglutide (online clinics): $99-350/month. Compounded tirzepatide: $350-550/month. Providers: Hims ($199-299/month), Ro ($145-290/month), Henry Meds ($297/month), Noom ($149/month). Insurance rarely covers weight loss indication, often covers diabetes use. Compounded versions are legal, safe, and significantly cheaper.
Q Are GLP-1 weight loss medications safe?
Yes, FDA-approved and considered safe for most people when prescribed appropriately. Common side effects (40-50% experience): nausea, vomiting, diarrhea, constipation—usually mild and temporary. Serious risks (rare): pancreatitis (<1%), gallstones (1-2%), kidney problems, thyroid tumors (animal studies, unclear human risk). Not safe for: history of medullary thyroid cancer, multiple endocrine neoplasia type 2, pregnant/breastfeeding. Long-term safety data (5+ years) is still emerging. Benefits typically outweigh risks for obesity treatment.
Q Do you have to inject GLP-1 medications?
Currently, yes—all FDA-approved GLP-1 medications for weight loss are injectable (semaglutide, tirzepatide, liraglutide). Injections are subcutaneous (under skin, not into muscle), weekly for semaglutide/tirzepatide, daily for liraglutide. Injections use small needles (similar to insulin) in abdomen, thigh, or upper arm. Oral semaglutide (Rybelsus) exists for diabetes but not approved/effective for weight loss. Most users report injections are easy and painless after first few times. Pill versions are in development but not yet available.
Q What happens when you stop taking GLP-1 medications?
Weight regain is common and expected. Clinical studies show: 70% of lost weight returns within 12 months of stopping. Appetite returns to pre-medication levels within 2-4 weeks. Some regain all weight lost, others maintain partial loss with lifestyle changes. To maintain weight loss after stopping: intensive lifestyle modification (diet, exercise), behavioral therapy, or transition to maintenance medication. Most doctors recommend indefinite use for obesity treatment, similar to managing chronic conditions like diabetes or hypertension.
Q Can anyone get a prescription for GLP-1 weight loss medication?
No, FDA approval requires: BMI 30+ (obesity), OR BMI 27+ with at least one weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea, PCOS). Not approved for: cosmetic weight loss, BMI <27 without medical conditions, people at healthy weight wanting to lose 5-10 pounds. Contraindications: pregnancy, history of medullary thyroid cancer, multiple endocrine neoplasia type 2. Legitimate telehealth providers verify BMI and medical eligibility before prescribing.
Q How long does it take for GLP-1 medications to work for weight loss?
Timeline for results: 2-4 weeks: reduced appetite, smaller portions, early weight loss (2-5 pounds). 4-8 weeks: noticeable weight loss (5-10 pounds), nausea typically subsides. 3-6 months: significant weight loss (10-15% of body weight). 12-18 months: peak weight loss (15-22% depending on medication). Weight loss continues for 12-18 months, then plateaus. Slower results at lower doses—dose escalation occurs over 4-5 months to minimize side effects.
Q What are the side effects of semaglutide and tirzepatide?
Common side effects (frequency): Nausea (40-50%), diarrhea (20-30%), vomiting (10-20%), constipation (15-20%), abdominal pain (10%), fatigue (10%), headache (10%). Most side effects: occur during dose escalation, peak at weeks 2-4, subside by week 8-12, are mild to moderate. Strategies to reduce: slow dose increases, eat smaller meals, avoid fatty foods, stay hydrated. Serious but rare: pancreatitis (<1%), gallstones (1-2%), severe dehydration from vomiting. About 5-10% discontinue due to intolerable side effects.
Q Is compounded semaglutide as effective as Wegovy?
Yes, compounded semaglutide contains the same active ingredient (semaglutide) at identical doses and is equally effective for weight loss. Differences: Compounded versions are made by FDA-registered 503B compounding pharmacies (legal and regulated), cost $99-350/month vs $900-1,400 for brand-name, may have slightly different inactive ingredients. The FDA allows compounding due to Wegovy shortages. Effectiveness is the same—15-17% average weight loss. However, compounded versions lack the same FDA approval process as brand-name medications.
Have more questions? Our research is continuously updated. If you don't see your question answered here, check our complete guides or contact our team.
References
- 1. Once-Weekly Semaglutide in Adults with Overweight or Obesity - New England Journal of Medicine
- 2. Tirzepatide Once Weekly for the Treatment of Obesity - New England Journal of Medicine